US 10457654
Therapeutic compounds and methods of use thereof
granted A61KA61K31/427A61P
Quick answer
US patent 10457654 (Therapeutic compounds and methods of use thereof) held by Xenon Pharmaceuticals Inc. expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/427, A61P, A61P17/04, A61P19/02